You have 9 free searches left this month | for more free features.

Condition

Advanced Hepatocellular Carcinoma (1)

Healthy Participants (1)

Hepatic Cancer (1)

Hepatic Carcinoma (1)

Hepatocellular Carcinoma (1)

Liver Cancer (1)

Liver Neoplasms (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Eisai Inc. (1)

H3 Biomedicine Inc. (1)

Collaborator

Eisai Inc. (1)

H3 Biomedicine Inc. (1)

Intervention

h3b-6527 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

h3b-6527

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer Trial in Worldwide (H3B-6527)

Completed

Advanced Hepatocellular Carcinoma
+5 more

H3B-6527

Los Angeles, California
+43 more

Apr 5, 2022

Healthy Participants Trial in San Antonio (H3B-6527)

Completed

Healthy Participants

H3B-6527

San Antonio, Texas

Worldwide Clinical Trials

Feb 1, 2018